Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 2 (2005), Issue 7 (July)

1. A community model for care of elderly people with diabetes via telemedicine.
   Appl Nurs Res, 18(2): 77-81. [Abstract] [Full-text]
2. Women with diabetes have poorer control of blood pressure than men.
   J Womens Health (Larchmt), 14(5): 418-23. [Abstract] [Full-text]
3. Antihyperlipidemic effect of Eugenia jambolana seed kernel on streptozotocin-induced diabetes in rats.
   Food Chem Toxicol, 43(9): 1433-9. [Abstract] [Full-text]
4. Involvement of circadian clock gene Clock in diabetes-induced circadian augmentation of plasminogen activator inhibitor-1 (PAI-1) expression in the mouse heart.
   FEBS Lett, 579(17): 3555-9. [Abstract] [Full-text]
5. Differential effects of diabetes on the expression of the gp91phox homologues nox1 and nox4.
   Free Radic Biol Med, 39(3): 381-91. [Abstract] [Full-text]
6. The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus.
   J Am Coll Cardiol, 46(1): 42-8. [Abstract] [Full-text]
7. 1267 HSP70-2 polymorphism as a risk factor for carotid plaque rupture and cerebral ischaemia in old type 2 diabetes-atherosclerotic patients.
   Mech Ageing Dev, 126(8): 866-73. [Abstract] [Full-text]
8. Streptozotocin-induced diabetes differentially modifies haloperidol- and gamma-hydroxybutyric acid (GHB)-induced catalepsy.
   Eur J Pharmacol, 517(1): 64-7. [Abstract] [Full-text]
9. Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis.
   Biochem Biophys Res Commun, 333(4): 1146-52. [Abstract] [Full-text]
10. Homodigital reverse flow island flap for reconstruction of neuropathic great toe ulcers in diabetic patients.
    Br J Plast Surg, 58(5): 717-9. [Abstract] [Full-text]
11. Diabetes-prone NOD mice show an expanded subpopulation of mature circulating monocytes, which preferentially develop into macrophage-like cells in vitro.
    J Leukoc Biol, 78(1): 70-9. [Abstract] [Full-text]
12. Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument.
    Arch Gen Psychiatry, 62(7): 726-33. [Abstract] [Full-text]
13. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience.
    Am J Transplant, 5(8): 2037-46. [Abstract] [Full-text]
14. Rosiglitazone protects against cyclosporine-induced pancreatic and renal injury in rats.
    Am J Transplant, 5(8): 1856-67. [Abstract] [Full-text]
15. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy.
    Proteomics, 5(10): 2648-55. [Abstract] [Full-text]
16. Genetic variability in the RAGE gene: possible implications for nutrigenetics, nutrigenomics, and understanding the susceptibility to diabetic complications.
    Mol Nutr Food Res, 49(7): 700-9. [Abstract] [Full-text]
17. Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress.
    Mol Nutr Food Res, 49(7): 685-90. [Abstract] [Full-text]
18. Coffee consumption and risk of type 2 diabetes: a systematic review.
    JAMA, 294(1): 97-104. [Abstract] [Full-text]
19. On practices of 'good doctoring': reconsidering the relationship between provider roles and patient adherence.
    Sociol Health Illn, 27(4): 421-47. [Abstract] [Full-text]
20. Effect of non-surgical periodontal treatment with or without doxycycline on the periodontium of type 1 diabetic patients.
    J Clin Periodontol, 32(8): 915-20. [Abstract] [Full-text]
21. A novel apoptosis-inducing anti-PSGL-1 antibody for T cell-mediated diseases.
    Eur J Immunol, 35(7): 2239-49. [Abstract] [Full-text]
22. Increased incidence of vertebral fracture in older female hemodialyzed patients with type 2 diabetes mellitus.
    Calcif Tissue Int, 76(4): 256-60. [Abstract] [Full-text]
23. New sources of pancreatic beta-cells.
    Nat Biotechnol, 23(7): 857-61. [Abstract] [Full-text]
24. Selective inhibition of Fcepsilon RI-mediated mast cell activation by a truncated variant of Cbl-b related to the rat model of type 1 diabetes mellitus.
    J Biochem (Tokyo), 137(6): 711-20. [Abstract] [Full-text]
25. Association of adiponectin level and variants in the adiponectin gene with glucose metabolism, energy expenditure, and cytokines in offspring of type 2 diabetic patients.
    J Clin Endocrinol Metab, 90(7): 4216-23. [Abstract] [Full-text]
26. Ovarian function during puberty in girls with type 1 diabetes mellitus: response to leuprolide.
    J Clin Endocrinol Metab, 90(7): 3939-45. [Abstract] [Full-text]
27. The prevalence of the metabolic syndrome in a danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population.
    J Clin Endocrinol Metab, 90(7): 4004-10. [Abstract] [Full-text]
28. Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus.
    J Clin Endocrinol Metab, 90(7): 3983-8. [Abstract] [Full-text]
29. Autosomal dominant neurohypophyseal diabetes insipidus with linkage to chromosome 20p13 but without mutations in the AVP-NPII gene.
    J Clin Endocrinol Metab, 90(7): 4388-93. [Abstract] [Full-text]
30. Obesity and type 2 diabetes do not alter splanchnic cortisol production in humans.
    J Clin Endocrinol Metab, 90(7): 3919-26. [Abstract] [Full-text]
31. Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model.
    Am J Physiol Renal Physiol, 289(2): F265-72. [Abstract] [Full-text]
32. Apolipoprotein A5 gene polymorphism -1131T-->C: association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese.
    Clin Chem Lab Med, 43(6): 607-12. [Abstract] [Full-text]
33. Circulating levels of nitrated apolipoprotein A-I are increased in type 2 diabetic patients.
    Clin Chem Lab Med, 43(6): 601-6. [Abstract] [Full-text]
34. Beta cell function and response to treatment in Nigerians with Type 2 diabetes mellitus.
    Diabetes Res Clin Pract, 69(2): 196-204. [Abstract] [Full-text]
35. Pathophysiologic heterogeneity in the development of type 2 diabetes mellitus in Korean subjects.
    Diabetes Res Clin Pract, 69(2): 180-7. [Abstract] [Full-text]
36. Alterations in peripheral blood levels of TIMP-1, MMP-2, and MMP-9 in patients with type-2 diabetes.
    Diabetes Res Clin Pract, 69(2): 175-9. [Abstract] [Full-text]
37. Incidence of Type 1 diabetes in children in Cáceres, Spain, during 1988-1999.
    Diabetes Res Clin Pract, 69(2): 169-74. [Abstract] [Full-text]
38. Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes.
    Diabetes Res Clin Pract, 69(2): 151-9. [Abstract] [Full-text]
39. Identification of a novel WFS1 mutation (AFF344-345ins) in Japanese patients with Wolfram syndrome.
    Diabetes Res Clin Pract, 69(2): 136-41. [Abstract] [Full-text]
40. Effects of Goshajinkigan on insulin resistance in patients with type 2 diabetes.
    Diabetes Res Clin Pract, 69(2): 129-35. [Abstract] [Full-text]
41. Evaluation of apolipoprotein E secretion by macrophages in type 2 diabetic patients: role of HDL and apolipoprotein A-I.
    Diabetes Res Clin Pract, 69(2): 124-8. [Abstract] [Full-text]
42. Increased gene expression of antioxidant enzymes in KKAy diabetic mice but not in STZ diabetic mice.
    Diabetes Res Clin Pract, 69(2): 113-9. [Abstract] [Full-text]
43. Dietary soy prevents brain Na+, K(+)-ATPase reduction in streptozotocin diabetic rats.
    Diabetes Res Clin Pract, 69(2): 107-12. [Abstract] [Full-text]
44. Strategies to prevent type 2 diabetes.
    Curr Med Res Opin, 21(7): 1107-14. [Abstract] [Full-text]
45. Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetes.
    Curr Med Res Opin, 21(7): 989-98. [Abstract] [Full-text]
46. Diabetes mellitus, tuberculosis and the mycobacteria: two millenia of enigma.
    Med Hypotheses, 65(3): 433-9. [Abstract] [Full-text]
47. Postprandial hypertriglyceridemia and carotid intima-media thickness in north Indian type 2 diabetic subjects.
    Diabetes Res Clin Pract, 69(2): 142-50. [Abstract] [Full-text]
48. Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes.
    J Clin Invest, 115(7): 1879-87. [Abstract] [Full-text]
49. Cholesterol synthesis is the trigger and isoprenoid dependent interleukin-6 mediated inflammation is the common causative factor and therapeutic target for atherosclerotic vascular disease and age-related disorders including osteoporosis and type 2 diabetes.
    Med Hypotheses, 65(3): 559-69. [Abstract] [Full-text]
50. Water extract of the root of Lindera strychnifolia slows down the progression of diabetic nephropathy in db/db mice.
    Life Sci, 77(12): 1391-403. [Abstract] [Full-text]
51. Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation.
    Am J Physiol Renal Physiol, 289(2): F420-30. [Abstract] [Full-text]
52. A randomized trial of electronic clinical reminders to improve quality of care for diabetes and coronary artery disease.
    J Am Med Inform Assoc, 12(4): 431-7. [Abstract] [Full-text]
53. An educational model for improving diet counselling in primary care A case study of the creative use of doctors' own diet, their attitudes to it and to nutritional counselling of their patients with diabetes.
    Patient Educ Couns, 58(2): 199-202. [Abstract] [Full-text]
54. The influence of participant's self-perceived role on metabolic outcomes in a diabetes group education program.
    Patient Educ Couns, 58(2): 137-45. [Abstract] [Full-text]
55. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
    Immunol Lett, 99(2): 180-5. [Abstract] [Full-text]
56. Diabetic ketoacidosis in children.
    Pediatr Clin North Am, 52(4): 1147-63, ix. [Abstract] [Full-text]
57. Keratoconjunctival effects of diabetes mellitus in dogs.
    Vet Ophthalmol, 8(4): 215-24. [Abstract] [Full-text]
58. Blood glucose in acute stroke, different therapeutic targets for diabetic and non-diabetic patients?
    Acta Neurol Scand, 112(2): 81-7. [Abstract] [Full-text]
59. Antioxidative treatment of pregnant diabetic rats diminishes embryonic dysmorphogenesis.
    Birth Defects Res A Clin Mol Teratol, 73(7): 498-505. [Abstract] [Full-text]
60. Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.
    Endocrinology, 146(8): 3622-31. [Abstract] [Full-text]
61. Deficiency of the very low-density lipoprotein (VLDL) receptors in streptozotocin-induced diabetic rats: insulin dependency of the VLDL receptor.
    Endocrinology, 146(8): 3286-94. [Abstract] [Full-text]
62. Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control.
    Diabetologia, 48(6): 1216-24. [Abstract] [Full-text]
63. A retrospective study of patients with diabetes mellitus after partial foot amputation and hyperbaric oxygen treatment.
    J Foot Ankle Surg, 44(4): 276-80. [Abstract] [Full-text]
64. No effect of taurine on platelet aggregation in men with a predisposition to type 2 diabetes mellitus.
    Platelets, 16(5): 301-5. [Abstract] [Full-text]
65. High prevalence of apical periodontitis amongst type 2 diabetic patients.
    Int Endod J, 38(8): 564-9. [Abstract] [Full-text]
66. Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan.
    Kidney Int, 68(2): 796-801. [Abstract] [Full-text]
67. C-reactive protein as a predictor of total arteriosclerotic outcomes in type 2 diabetic nephropathy.
    Kidney Int, 68(2): 773-8. [Abstract] [Full-text]
68. P-selectin gene haplotype associations with albuminuria in the Diabetes Heart Study.
    Kidney Int, 68(2): 741-6. [Abstract] [Full-text]
69. Expression of concentrative nucleoside transporters SLC28 (CNT1, CNT2, and CNT3) along the rat nephron: effect of diabetes.
    Kidney Int, 68(2): 665-72. [Abstract] [Full-text]
70. Mesangial accumulation of GA-pyridine, a novel glycolaldehyde-derived AGE, in human renal disease.
    Kidney Int, 68(2): 595-602. [Abstract] [Full-text]
71. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy.
    Kidney Int, 68(2): 552-61. [Abstract] [Full-text]
72. Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice.
    Nat Med, 11(7): 765-73. [Abstract] [Full-text]
73. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes.
    Am J Physiol Heart Circ Physiol, 289(2): H701-7. [Abstract] [Full-text]
74. Cardiomyocyte apoptosis induced by short-term diabetes requires mitochondrial GSH depletion.
    Am J Physiol Heart Circ Physiol, 289(2): H768-76. [Abstract] [Full-text]
75. Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats.
    Am J Physiol Endocrinol Metab, 289(2): E328-36. [Abstract] [Full-text]
76. Effects of glycemic control on target organ responses to epinephrine in type 1 diabetes.
    Am J Physiol Endocrinol Metab, 289(2): E258-65. [Abstract] [Full-text]
77. Alpha-Ketoisocaproate-induced hypersecretion of insulin by islets from diabetes-susceptible mice.
    Am J Physiol Endocrinol Metab, 289(2): E218-24. [Abstract] [Full-text]
78. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization.
    Am J Obstet Gynecol, 193(1): 118-24. [Abstract] [Full-text]
79. Wider income gaps, wider waistbands? An ecological study of obesity and income inequality.
    J Epidemiol Community Health, 59(8): 670-4. [Abstract] [Full-text]
80. The effectiveness of an interactive small group diabetes intervention in improving knowledge, feeling of control, and behavior.
    Health Promot Pract, 6(3): 320-8. [Abstract] [Full-text]
81. Fat as an endocrine organ: influence of exercise.
    J Appl Physiol, 99(2): 757-64. [Abstract] [Full-text]
82. Endothelial F-actin cytoskeleton in the retinal vasculature of normal and diabetic rats.
    Curr Eye Res, 30(4): 279-90. [Abstract] [Full-text]
83. Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum.
    Ann Med, 37(4): 250-8. [Abstract] [Full-text]
84. Molecular mechanisms of mitochondrial diabetes (MIDD).
    Ann Med, 37(3): 213-21. [Abstract] [Full-text]
85. Mutations in the Kir6.2 subunit of the KATP channel and permanent neonatal diabetes: new insights and new treatment.
    Ann Med, 37(3): 186-95. [Abstract] [Full-text]
86. Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS 1): study design and research methodology.
    Ophthalmic Epidemiol, 12(2): 143-53. [Abstract] [Full-text]
87. Sex-related differences in tuberculin reaction, free and total testosterone concentrations in patients with autoimmune disorders and controls.
    Int J Neurosci, 115(6): 911-6. [Abstract] [Full-text]
88. Diagnostic controversy: gestational diabetes and the meaning of risk for pima Indian women.
    Med Anthropol, 24(2): 145-77. [Abstract] [Full-text]
89. Soluble P-selectin levels in diabetes mellitus patients with coronary artery disease.
    Hematology, 10(3): 183-7. [Abstract] [Full-text]
90. Influence of revascularization on long-term outcome in patients > or =75 years of age with diabetes mellitus and angina pectoris.
    Am J Cardiol, 96(2): 193-8. [Abstract] [Full-text]
91. Comparison of specificity of quantitative myocardial contrast echocardiography for diagnosis of coronary artery disease in patients with versus without diabetes mellitus.
    Am J Cardiol, 96(2): 187-92. [Abstract] [Full-text]
92. Umbilical artery resistance index in diabetic pregnancies: the associations with fetal outcome and neonatal septal hypertrophic cardiomyopathy.
    J Obstet Gynaecol Res, 31(4): 296-301. [Abstract] [Full-text]
93. Felodipine-influenced gingival enlargement in an uncontrolled type 2 diabetic patient.
    J Periodontol, 76(7): 1217. [Abstract] [Full-text]
94. Protective role for cytosolic phospholipase A2alpha in autoimmune diabetes of mice.
    FEBS Lett, 579(18): 3975-8. [Abstract] [Full-text]
95. PPARgamma agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats.
    Biochem Biophys Res Commun, 334(1): 176-82. [Abstract] [Full-text]
96. Effects of endurance exercise-training on single-fiber contractile properties of insulin-treated streptozotocin-induced diabetic rats.
    J Appl Physiol, 99(2): 472-8. [Abstract] [Full-text]
97. Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery?
    Eur Heart J, 26(15): 1513-8. [Abstract] [Full-text]
98. Rapid onset of quetiapine-induced diabetic ketoacidosis in an elderly patient: a case report.
    Pharmacopsychiatry, 38(4): 183-4. [Abstract] [Full-text]
99. Differences in type I diabetes mellitus of young adults with and without thyroid autoimmunity.
    Exp Clin Endocrinol Diabetes, 113(7): 404-8. [Abstract] [Full-text]
100. In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans.
     Exp Clin Endocrinol Diabetes, 113(7): 388-95. [Abstract] [Full-text]
101. Quantitative evaluation of a monoclonal antibody and its fragment as potential markers for pancreatic beta cell mass.
     Exp Clin Endocrinol Diabetes, 113(7): 381-7. [Abstract] [Full-text]
102. PGE1 inhibits the expression of PAI-1 mRNA induced by TNF-alpha in human mesangial cells.
     Exp Clin Endocrinol Diabetes, 113(7): 365-71. [Abstract] [Full-text]
103. Skull base osteomyelitis: diagnostic and therapeutic challenges in atypical presentation.
     Otolaryngol Head Neck Surg, 133(1): 121-5. [Abstract] [Full-text]
104. Cochlear changes in patients with type 1 diabetes mellitus.
     Otolaryngol Head Neck Surg, 133(1): 100-6. [Abstract] [Full-text]
105. In vivo evaluation of ocular inflammatory responses in experimental diabetes.
     Br J Ophthalmol, 89(8): 1052-7. [Abstract] [Full-text]
106. Effect of tranexamic acid on early postvitrectomy diabetic haemorrhage; a randomised clinical trial.
     Br J Ophthalmol, 89(8): 1041-4. [Abstract] [Full-text]
107. Dosage dependency of intravitreal triamcinolone acetonide as treatment for diabetic macular oedema.
     Br J Ophthalmol, 89(8): 999-1003. [Abstract] [Full-text]
108. An evaluation of the change in activity and workload arising from diabetic ophthalmology referrals following the introduction of a community based digital retinal photographic screening programme.
     Br J Ophthalmol, 89(8): 971-5. [Abstract] [Full-text]
109. Principles of management: the diabetic foot.
     Am J Surg, 190(2): 295-9. [Abstract] [Full-text]
110. Metabolic syndrome and risk of cardiovascular events after myocardial infarction.
     J Am Coll Cardiol, 46(2): 277-83. [Abstract] [Full-text]
111. Adiponectin receptor 2 expression in liver and insulin resistance in db/db mice given a beta3-adrenoceptor agonist.
     Eur J Pharmacol, 518(1): 71-6. [Abstract] [Full-text]
112. Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids.
     Br J Pharmacol, 145(6): 767-74. [Abstract] [Full-text]
113. Effect of tempol on renal cyclooxygenase expression and activity in experimental diabetes in the rat.
     J Pharmacol Exp Ther, 314(2): 818-24. [Abstract] [Full-text]
114. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
     J Pharmacol Exp Ther, 314(2): 514-21. [Abstract] [Full-text]
115. Epidermal growth factor receptor tyrosine kinase-mediated signalling contributes to diabetes-induced vascular dysfunction in the mesenteric bed.
     Br J Pharmacol, 145(6): 829-36. [Abstract] [Full-text]
116. Microalbuminuria and abnormal ambulatory blood pressure in adolescents with type 2 diabetes mellitus.
     J Pediatr, 147(1): 67-73. [Abstract] [Full-text]
117. Nurse case manager effectiveness and case load in a large clinical practice: implications for workforce development.
     Diabet Med, 22(8): 1116-20. [Abstract] [Full-text]
118. Implementation of national diabetes retinal screening programme is associated with a lower proportion of patients referred to ophthalmology.
     Diabet Med, 22(8): 1112-5. [Abstract] [Full-text]
119. Increases in body mass index, even within non-obese levels, raise the risk for Type 2 diabetes mellitus: a follow-up study in a Japanese population.
     Diabet Med, 22(8): 1107-11. [Abstract] [Full-text]
120. Long-term effects of pioglitazone and metformin on insulin sensitivity in patients with Type 2 diabetes mellitus.
     Diabet Med, 22(8): 1101-6. [Abstract] [Full-text]
121. Clustering of protective factors for glucose intolerance and insulin resistance: a cross-sectional study.
     Diabet Med, 22(8): 1091-7. [Abstract] [Full-text]
122. Patterns of care as a risk factor for the development of vision-threatening diabetic retinopathy: a population-based matched case-control study using insurance claims (Medicare) data.
     Diabet Med, 22(8): 1083-90. [Abstract] [Full-text]
123. Coeliac disease in children with Type 1 diabetes mellitus: the effect of the gluten-free diet.
     Diabet Med, 22(8): 1079-82. [Abstract] [Full-text]
124. High prevalence and severity of cardiac autonomic neuropathy in Vietnamese diabetic patients.
     Diabet Med, 22(8): 1072-8. [Abstract] [Full-text]
125. The effect of manipulation of basal pulsatile insulin on insulin action in Type 2 diabetes.
     Diabet Med, 22(8): 1064-71. [Abstract] [Full-text]
126. Does close glycaemic control promote healing in diabetic foot ulcers? Report of a feasibility study.
     Diabet Med, 22(8): 1060-3. [Abstract] [Full-text]
127. Association of angiotensin-converting enzyme DD genotype with 24-h blood pressure abnormalities in normoalbuminuric children and adolescents with Type 1 diabetes.
     Diabet Med, 22(8): 1054-9. [Abstract] [Full-text]
128. Socio-economic inequalities in the prevalence of Type 2 diabetes, cardiovascular risk factors and chronic diabetic complications in the Basque Country, Spain.
     Diabet Med, 22(8): 1047-53. [Abstract] [Full-text]
129. Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients.
     Diabet Med, 22(8): 1037-46. [Abstract] [Full-text]
130. Reporting of diabetes on death certificates using data from the UK Prospective Diabetes Study.
     Diabet Med, 22(8): 1031-6. [Abstract] [Full-text]
131. Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes.
     Diabet Med, 22(8): 1024-30. [Abstract] [Full-text]
132. Effects of liraglutide (NN2211), a long-acting GLP-1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes.
     Diabet Med, 22(8): 1016-23. [Abstract] [Full-text]
133. Diagnostic screening of NEUROD1 (MODY6) in subjects with MODY or gestational diabetes mellitus.
     Diabet Med, 22(8): 1012-5. [Abstract] [Full-text]
134. Impairment of cardiac function in hypertensive patients with Type 2 diabetes: a LIFE study.
     Diabet Med, 22(8): 1005-11. [Abstract] [Full-text]
135. Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
     Diabet Med, 22(8): 999-1004. [Abstract] [Full-text]
136. Clinical characteristics of mutation carriers in a large family with glucokinase diabetes (MODY2).
     Diabet Med, 22(8): 994-8. [Abstract] [Full-text]
137. Pioglitazone initiation and subsequent hospitalization for congestive heart failure.
     Diabet Med, 22(8): 986-93. [Abstract] [Full-text]
138. Comparison of metabolic effects of pioglitazone, metformin, and glimepiride over 1 year in Japanese patients with newly diagnosed Type 2 diabetes.
     Diabet Med, 22(8): 980-5. [Abstract] [Full-text]
139. Changes in liver tests during 1-year treatment of patients with Type 2 diabetes with pioglitazone, metformin or gliclazide.
     Diabet Med, 22(8): 973-9. [Abstract] [Full-text]
140. Beta-cell preservation: a potential role for thiazolidinediones to improve clinical care in Type 2 diabetes.
     Diabet Med, 22(8): 963-72. [Abstract] [Full-text]
141. Cost-effectiveness of type 2 diabetes screening: results from recently published studies.
     Gesundheitswesen, 67: S167-71. [Abstract] [Full-text]
142. Health inequalities among persons with type 2 diabetes: the example of intermittent claudication.
     Gesundheitswesen, 67: S137-43. [Abstract] [Full-text]
143. Genetics of type 2 diabetes: impact of interleukin-6 gene variants.
     Gesundheitswesen, 67: S122-6. [Abstract] [Full-text]
144. Inflammation and type 2 diabetes: results from KORA Augsburg.
     Gesundheitswesen, 67: S115-21. [Abstract] [Full-text]
145. The diabetes epidemic in the elderly population in Western Europe: data from population-based studies.
     Gesundheitswesen, 67: S110-4. [Abstract] [Full-text]
146. Type 2 diabetes mellitus in Augsburg--an epidemiological overview.
     Gesundheitswesen, 67: S103-9. [Abstract] [Full-text]
147. Toll-like receptor 3 gene polymorphisms in South African Blacks with type 1 diabetes.
     Tissue Antigens, 66(2): 125-30. [Abstract] [Full-text]
148. Unilateral macular oedema secondary to retinal venous congestion without occlusion in patients with diabetes mellitus.
     Acta Ophthalmol Scand, 83(4): 428-35. [Abstract] [Full-text]
149. Diabetes mellitus concomitantly facilitates the induction of long-term depression and inhibits that of long-term potentiation in hippocampus.
     Eur J Neurosci, 22(1): 169-78. [Abstract] [Full-text]
150. Tumor necrosis factor alpha system and plasma adiponectin concentration in women with gestational diabetes.
     Horm Metab Res, 37(7): 450-4. [Abstract] [Full-text]
151. Impact of smoking on the metabolic action of subcutaneous regular insulin in type 2 diabetic patients.
     Horm Metab Res, 37(7): 445-9. [Abstract] [Full-text]
152. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes.
     Nature, 436(7049): 356-62. [Abstract] [Full-text]
153. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.
     N Engl J Med, 353(3): 238-48. [Abstract] [Full-text]
154. Vascular complications in diabetes mellitus: the role of endothelial dysfunction.
     Clin Sci (Lond), 109(2): 143-59. [Abstract] [Full-text]
155. Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
     J Med Chem, 48(15): 5025-37. [Abstract] [Full-text]
156. Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes.
     Clin Sci (Lond), 109(2): 189-97. [Abstract] [Full-text]
157. Tissue-specific variation in glycation of proteins in diabetes: evidence for a functional role of amadoriase enzymes.
     Ann N Y Acad Sci, 1043: 817-23. [Abstract] [Full-text]
158. Post-Amadori AGE inhibition as a therapeutic target for diabetic complications: a rational approach to second-generation Amadorin design.
     Ann N Y Acad Sci, 1043: 793-806. [Abstract] [Full-text]
159. Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes.
     Ann N Y Acad Sci, 1043: 784-92. [Abstract] [Full-text]
160. High-dose thiamine therapy counters dyslipidemia and advanced glycation of plasma protein in streptozotocin-induced diabetic rats.
     Ann N Y Acad Sci, 1043: 777-83. [Abstract] [Full-text]
161. Renoprotective and lipid-lowering effects of LR compounds, novel advanced glycation end product inhibitors, in streptozotocin-induced diabetic rats.
     Ann N Y Acad Sci, 1043: 767-76. [Abstract] [Full-text]
162. Advanced glycation end products in diabetes-associated atherosclerosis and renal disease: interventional studies.
     Ann N Y Acad Sci, 1043: 759-66. [Abstract] [Full-text]
163. Can advanced glycation end product inhibitors modulate more than one pathway to enhance renoprotection in diabetes?
     Ann N Y Acad Sci, 1043: 750-8. [Abstract] [Full-text]
164. Plasma levels of AGE peptides in type 1 diabetic patients are associated with serum creatinine and not with albumin excretion rate: possible role of AGE peptide-associated endothelial dysfunction.
     Ann N Y Acad Sci, 1043: 662-70. [Abstract] [Full-text]
165. Plasma low-molecular weight fluorescence in type 1 diabetes mellitus.
     Ann N Y Acad Sci, 1043: 655-61. [Abstract] [Full-text]
166. Significance of proximal tubular metabolism of advanced glycation end products in kidney diseases.
     Ann N Y Acad Sci, 1043: 637-43. [Abstract] [Full-text]
167. Processing advanced glycation end product-modified albumin by the renal proximal tubule and the early pathogenesis of diabetic nephropathy.
     Ann N Y Acad Sci, 1043: 625-36. [Abstract] [Full-text]
168. Synergistic contributions of carbonyl stress and megsin in diabetic nephropathy.
     Ann N Y Acad Sci, 1043: 605-8. [Abstract] [Full-text]
169. Role of advanced glycation end products and their receptors in development of diabetic neuropathy.
     Ann N Y Acad Sci, 1043: 598-604. [Abstract] [Full-text]
170. Glycation products as markers and predictors of the progression of diabetic complications.
     Ann N Y Acad Sci, 1043: 567-81. [Abstract] [Full-text]
171. Receptor for advanced glycation end products is a promising target of diabetic nephropathy.
     Ann N Y Acad Sci, 1043: 562-6. [Abstract] [Full-text]
172. Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis.
     Ann N Y Acad Sci, 1043: 553-61. [Abstract] [Full-text]
173. Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution".
     Ann N Y Acad Sci, 1043: 533-44. [Abstract] [Full-text]
174. Are food advanced glycation end products toxic in biological systems?
     Ann N Y Acad Sci, 1043: 467-73. [Abstract] [Full-text]
175. Lipid-derived modifications of plasma proteins in experimental and human diabetes.
     Ann N Y Acad Sci, 1043: 404-12. [Abstract] [Full-text]
176. Intrauterine programming of urinary calcium and magnesium excretion in children born to mothers with insulin dependent diabetes mellitus.
     Arch Dis Child Fetal Neonatal Ed, 90(4): F332-6. [Abstract] [Full-text]
177. Quality of life of patients with diabetes mellitus. An overview of research in primary health care in the Nordic countries.
     Scand J Prim Health Care, 23(2): 68-74. [Abstract] [Full-text]
178. Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate-to-severe reductions in renal function.
     Blood Press, 14(3): 170-6. [Abstract] [Full-text]
179. Endothelin A antagonist LU-135252 and trandolapril in the treatment of the Cohen-Rosenthal diabetic hypertensive rat.
     Blood Press, 14(2): 114-9. [Abstract] [Full-text]
180. Regulatory T cells in the control of autoimmune diabetes: the case of the NOD mouse.
     Int Rev Immunol, 24(3): 247-67. [Abstract] [Full-text]
181. Endothelin inhibition delays onset of hyperglycemia and associated vascular injury in type I diabetes: evidence for endothelin release by pancreatic islet beta-cells.
     Biochem Biophys Res Commun, 334(2): 689-95. [Abstract] [Full-text]
182. Differentiation between Candida species isolated from diabetic foot by fatty acid methyl ester analysis using gas chromatography.
     J Chromatogr B Analyt Technol Biomed Life Sci, 822(1): 118-23. [Abstract] [Full-text]
183. Insulin-like growth factor-1 and its binding proteins, IGFBP-1 and IGFBP-3, in adolescents with type-1 diabetes mellitus and microalbuminuria.
     Horm Res, 63(5): 245-51. [Abstract] [Full-text]
184. Myricetin as the active principle of Abelmoschus moschatus to lower plasma glucose in streptozotocin-induced diabetic rats.
     Planta Med, 71(7): 617-21. [Abstract] [Full-text]
185. Women with palmoplantar pustulosis have disturbed calcium homeostasis and a high prevalence of diabetes mellitus and psychiatric disorders: a case-control study.
     Acta Derm Venereol, 85(3): 225-32. [Abstract] [Full-text]
186. Efficacy of clonal deletion vs. anergy of self-reactive CD4 T-cells for the prevention and reversal of autoimmune diabetes.
     J Autoimmun, 25(1): 21-32. [Abstract] [Full-text]
187. Genetic and functional association of the immune signaling molecule 4-1BB (CD137/TNFRSF9) with type 1 diabetes.
     J Autoimmun, 25(1): 13-20. [Abstract] [Full-text]
188. T-cell homing to the pancreas in autoimmune mouse models of diabetes: in vivo MR imaging.
     Radiology, 236(2): 579-87. [Abstract] [Full-text]
189. Regional patterns of sight-threatening diabetic macular edema.
     Am J Ophthalmol, 140(1): 117-24. [Abstract] [Full-text]
190. The uncoupling protein 2 Ala55Val polymorphism is associated with diabetes mellitus: the CARDIA study.
     Clin Chem, 51(8): 1451-6. [Abstract] [Full-text]
191. Visual dysfunction after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.
     Am J Ophthalmol, 140(1): 8-15. [Abstract] [Full-text]
192. Defects in differentiation of bone-marrow derived dendritic cells of the BB rat are partly associated with IDDM2 (the lyp gene) and partly associated with other genes in the BB rat background.
     J Autoimmun, 25(1): 46-56. [Abstract] [Full-text]
193. Drug intervention can correct subnormal retinal oxygenation response in experimental diabetic retinopathy.
     Invest Ophthalmol Vis Sci, 46(8): 2954-60. [Abstract] [Full-text]
194. The RAGE axis in early diabetic retinopathy.
     Invest Ophthalmol Vis Sci, 46(8): 2916-24. [Abstract] [Full-text]
195. Monocarboxylate transporter expression remains unchanged during the development of diabetic retinal neuropathy in the rat.
     Invest Ophthalmol Vis Sci, 46(8): 2878-85. [Abstract] [Full-text]
196. Expression of the IGF system in normal and diabetic transgenic (mRen-2)27 rat eye.
     Invest Ophthalmol Vis Sci, 46(8): 2708-15. [Abstract] [Full-text]
197. Plasma C peptide level and cognitive function among older women without diabetes mellitus.
     Arch Intern Med, 165(14): 1651-6. [Abstract] [Full-text]
198. Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study.
     Arch Intern Med, 165(14): 1612-7. [Abstract] [Full-text]
199. Wolframin mutations and hospitalization for psychiatric illness.
     Mol Psychiatry, 10(8): 799-803. [Abstract] [Full-text]
200. An increased MRP8/14 expression and adhesion, but a decreased migration towards proinflammatory chemokines of type 1 diabetes monocytes.
     Clin Exp Immunol, 141(3): 509-17. [Abstract] [Full-text]
201. Effect of the menstrual cycle on the optic nerve head in diabetes: analysis by confocal scanning laser ophthalmoscopy.
     Can J Ophthalmol, 40(2): 175-82. [Abstract] [Full-text]
202. Young adults' (16-25 years) suggestions for providing developmentally appropriate diabetes services: a qualitative study.
     Health Soc Care Community, 13(5): 409-19. [Abstract] [Full-text]
203. The diabetes experiences of Aboriginal people living in a rural Canadian community.
     Aust J Rural Health, 13(4): 242-6. [Abstract] [Full-text]
204. Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes.
     Nat Genet, 37(8): 863-7. [Abstract] [Full-text]
205. Contraceptive use by diabetic and obese women.
     Womens Health Issues, 15(4): 167-73. [Abstract] [Full-text]
206. Spondylodiscitis: diagnosis and treatment.
     Surg Neurol, 64(2): 103-8; discussion 108. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.